Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. (Q45976411)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. |
scientific article |
Statements
1 reference
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. (English)
1 reference
1 reference
J D Hainsworth
1 reference
S Jeffers
1 reference
P Miller
1 reference
S Groshen
1 reference
M Tan
1 reference
L Roman
1 reference
B Uziely
1 reference
L Muderspach
1 reference
A Garcia
1 reference
A Burnett
1 reference
F A Greco
1 reference
C P Morrow
1 reference
L J Paradiso
1 reference
L J Liang
1 reference
1 March 1997
1 reference
15
1 reference
3
1 reference
987-993
1 reference